SPRB
Spruce Biosciences, Inc.
45.70$
+2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.9% | -6.3% | -20.0% | -16.7% | -10.0% | -33.3% | +16.7% | -57.1% | +66.7% | +4,940.0% | +150.4% | – | |
| – | +8.8% | +27.9% | +7.9% | -32.3% | -15.7% | -43.4% | -114.2% | – | +307.7% | -59.3% | +26.4% | – | |
| – | – | – | – | – | – | -53.6% | -834.7% | – | +4.3% | +1.0% | -322.8% | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | +1,250.0% | – | |
| – | -33.5% | – | – | – | – | – | – | – | – | – | +1,250.0% | – | |
| – | – | -99.1% | +450.0% | – | – | – | – | – | +733.3% | – | – | – | |
| – | – | – | – | – | +0.2% | -0.2% | +0.2% | -0.2% | +107.7% | – | -100.0% | – | |
| – | +36.3% | -58.9% | +60.8% | +11.0% | +54.3% | -34.2% | -2.7% | +0.5% | – | -68.9% | +363.3% | – | |
| – | -286.7% | – | – | – | – | – | – | – | – | -86.5% | +715.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.